Skip to main content
Clinical Trials/NCT01535001
NCT01535001
Completed
Not Applicable

Structured Non-operative Treatment of Knee Osteoarthritis - a Randomized Controlled Trial of Pain, Physical Function and Quality of Life With 12months Follow-up

Northern Orthopaedic Division, Denmark3 sites in 1 country100 target enrollmentFebruary 2012

Overview

Phase
Not Applicable
Intervention
Neuromuscular training (NEMEX-TJR)
Conditions
Osteoarthritis of the Knee
Sponsor
Northern Orthopaedic Division, Denmark
Enrollment
100
Locations
3
Primary Endpoint
Change From Baseline in KOOS4 (Knee Injury and Osteoarthritis Outcome Score)
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

The purpose of this study is to test whether an algorithm for systematic non-surgical treatment consisting of corrective insoles, neuromuscular training, weight loss, patient education and pharmacological treatment with paracetamol, non steroidal anti inflammatory drugs (NSAIDs) and Pantoprazole provides further improvement in pain, function and quality of life than standard non-surgical treatment (information on the disease and how to treat it) in patients with knee osteoarthritis.

The H1-hypothesis is that the treatment algorithm results in a greater increase in quality of life and functional capacity and greater reduction in pain than standard treatment at the primary endpoint, which is follow-up 12months after the start of the treatment.

See statistical analysis plan available under "Links" for further description of the study.

Detailed Description

Knee osteoarthritis (OA) is the degenerative joint disease that most often requires treatment and at the same time the one associated with the greatest social costs. In addition, the disease has many personal costs and is greatly contributing to reduced functionality and autonomy of older adults. It is recommended both nationally and internationally that the treatment of knee osteoarthritis should include multiple treatment modalities. Clinical guidelines recommend that exercise, weight loss and patient education is the first step in treatment and that insoles and pharmacological treatment can be included as a supplement. However if the patient is not a candidate for total knee replacement, the patient most often receives only information on knee osteoarthritis, and on what they can do to treat the disorder and prevent it from being worse. This postponement of treatment can lead to a worsening of pain and function and a worse outcome after treatment. Therefore, the current treatment strategy for the patient group is problematic. The current practice may be due to the lack of studies with high level of evidence that have examined the optimal non-operative treatment approach and compared it with the current standard treatment for this group of patients.

Registry
clinicaltrials.gov
Start Date
February 2012
End Date
September 2014
Last Updated
8 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Northern Orthopaedic Division, Denmark
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Knee-OA detected by x-ray (Kellgren \& Lawrence grade 1 or greater)
  • KOOS4 of ≤ 75
  • Considered not to be a candidate for Total Knee Replacement (TKR) by the orthopedic surgeon.
  • The participant is \> 18 years of age.
  • The participant can provide relevant and adequate, informed consent.

Exclusion Criteria

  • Prior TKA ipsilateral
  • Rheumatoid arthritis
  • Mean VAS \> 60mm the last week on a 0-100mm scale
  • Possible pregnancy or planning pregnancy;
  • Inability to comply with the protocol;
  • Inadequacy in written and spoken Danish.

Arms & Interventions

MEDIC

Medicine, Exercise, Diet, Insole and Cognitive/patient education (MEDIC) for three months.

Intervention: Neuromuscular training (NEMEX-TJR)

MEDIC

Medicine, Exercise, Diet, Insole and Cognitive/patient education (MEDIC) for three months.

Intervention: Paracetamol

MEDIC

Medicine, Exercise, Diet, Insole and Cognitive/patient education (MEDIC) for three months.

Intervention: Burana

MEDIC

Medicine, Exercise, Diet, Insole and Cognitive/patient education (MEDIC) for three months.

Intervention: Pantoprazole

MEDIC

Medicine, Exercise, Diet, Insole and Cognitive/patient education (MEDIC) for three months.

Intervention: Dietary counseling

MEDIC

Medicine, Exercise, Diet, Insole and Cognitive/patient education (MEDIC) for three months.

Intervention: Patient education

MEDIC

Medicine, Exercise, Diet, Insole and Cognitive/patient education (MEDIC) for three months.

Intervention: Insoles

Standard treatment

Information on knee osteoarthritis, and on what they can do to treat the disorder and prevent it from being worse.

Intervention: Information

Outcomes

Primary Outcomes

Change From Baseline in KOOS4 (Knee Injury and Osteoarthritis Outcome Score)

Time Frame: Primary: 12months.

The average score for four of the five KOOS subscales, covering pain, symptoms, difficulties in functions of daily living, and quality of life (KOOS4), with scores ranging from 0 (worst) to 100 (best). Between group comparisons of treatment effect (change in KOOS4 from baseline to 1 year follow-up) will be dependent on data distribution. We expect the change to be normally distributed and analysis will be made using a mixed model ANOVA with subject being a random factor and visit (baseline, 3, 6 and 12 months), treatment arm (TKA + MEDIC, MEDIC) and site (Frederikshavn, Farsoe) being fixed factors. Baseline KOOS4 will be a covariate. Furthermore interactions between the fixed factors will be included in the model. P-values and 95% CI will be presented to assess superiority.

Secondary Outcomes

  • Change From Baseline in 20-meter Walk(Primary: 12months.)
  • Change in the Five KOOS Subscale Scores From Baseline(Primary: 12 months.)
  • Proportion of Users of Pain Medication(Baseline and 12months.)
  • Change From Baseline in EQ-5D(Primary: 12months.)
  • Weight Change in kg From Baseline(Primary: 12months.)
  • Number of Serious Adverse Events Reported at Index Knee(Primary: 12months.)
  • Change From Baseline in Time From the Timed Up and Go(Primary: 12 months.)

Study Sites (3)

Loading locations...

Similar Trials